Zeneca To Expand US Field Force

20 January 1997

Zeneca Pharmaceuticals is to recruit and train 250 new contract salesrepresentatives in the USA who will focus their efforts on reaching cardiovascular physicians, the firm said.

This expansion follows that undertaken by Zeneca early last year, when the firm supplemented its US field team by expanding its comprehensive care, primary care and oncology care sales forces.

Bill Simpson, national business director in the USA said: "to take advantage of the extra selling opportunities our robust product line offers, we recognize the need to increase our representation in the field. We'll continue to explore additional avenues to grow our business and maintain the Zeneca presence necessary to remain a leader in the highly competitive US pharmaceutical market."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight